Dr. Allen Raymond Doan is a pharmacist who is specialized in Nuclear in Marquette, Michigan. Patients can reach him at 2296 Us 41 S, Marquette or contact him on 906-273-1306. Active license number of Dr. Allen Raymond Doan is 5302033248 for Nuclear in Michigan. Dr. Allen Raymond Doan is a licensed pharmacist who has demonstrated specialized knowledge and skill in procurement, compounding, quality control testing, dispensing, distribution, and monitoring of radiopharmaceuticals.
Complete Profile:
Dr. Allen Raymond Doan speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Allen Raymond Doan
Specialization:
Nuclear
Credentials:
PHARMD
Gender:
Male
Location:
2296 Us 41 S, Marquette, Michigan, 49855-9119
Phone:
906-273-1306
Fax:
906-273-1307
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Allen Raymond Doan are as mentioned below.
NPI Number:
1104260140
NPI Enumeration Date:
22 Apr, 2013
NPI Last Update On:
22 Apr, 2013
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Allen Raymond Doan are as mentioned below.
Specialization
License Number
State
Status
Nuclear
5302033248
Michigan
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2296 Us 41 S, Marquette, Michigan
Zip:
49855-9119
Phone Number:
906-273-1306
Fax Number:
906-273-1307
Patients can reach Dr. Allen Raymond Doan at 2296 Us 41 S, Marquette, Michigan or can call on phone at 906-273-1306.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.